Evolent Health Inc (EVH)
29.26
-0.87
(-2.89%)
USD |
NYSE |
Apr 24, 16:00
29.26
0.00 (0.00%)
After-Hours: 20:00
Evolent Health Revenue (TTM): 1.964B for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.964B |
| September 30, 2023 | 1.790B |
| June 30, 2023 | 1.632B |
| March 31, 2023 | 1.483B |
| December 31, 2022 | 1.352B |
| September 30, 2022 | 1.218B |
| June 30, 2022 | 1.088B |
| March 31, 2022 | 989.94M |
| December 31, 2021 | 907.96M |
| September 30, 2021 | 906.14M |
| June 30, 2021 | 923.24M |
| March 31, 2021 | 918.48M |
| December 31, 2020 | 924.64M |
| September 30, 2020 | 755.37M |
| June 30, 2020 | 735.94M |
| March 31, 2020 | 710.60M |
| Date | Value |
|---|---|
| December 31, 2019 | 687.12M |
| September 30, 2019 | 802.96M |
| June 30, 2019 | 732.77M |
| March 31, 2019 | 685.10M |
| December 31, 2018 | 627.06M |
| September 30, 2018 | 547.69M |
| June 30, 2018 | 505.65M |
| March 31, 2018 | 468.43M |
| December 31, 2017 | 434.95M |
| September 30, 2017 | 409.23M |
| June 30, 2017 | 361.53M |
| March 31, 2017 | 310.98M |
| December 31, 2016 | 254.19M |
| September 30, 2016 | 212.24M |
| June 30, 2016 | 192.43M |
| March 31, 2016 | 146.33M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
687.12M
Minimum
Dec 2019
1.964B
Maximum
Dec 2023
1.080B
Average
923.24M
Median
Jun 2021
Revenue (TTM) Benchmarks
| American Shared Hospital Services | 21.32M |
| Novo Integrated Sciences Inc | 13.66M |
| Astrana Health Inc | 1.387B |
| Cryo-Cell International Inc | 31.37M |
| P3 Health Partners Inc | 1.266B |